Literature DB >> 528567

Incorporation studies of nucleic acid precursors in gastric cancer: an attempt in individualized chemotherapy.

P Schlag, J Veser, G Geier, D Breitig, P Merkle.   

Abstract

Measurements of the rate of incorporation of radioactively labeled nucleic acid precursors into the DNA and RNA of gastric carcinoma cell suspensions indicated variable rates of proliferation for the tumors. The rate of incorporation generally correlates to the cytological level of differentiation of the carcinoma. Reduced differentiation of the tumors showed a corresponding increase in the rate of proliferation. Knowing the proliferation-dependent effect of most cytostatica, this results in a resistance to cytostatica of highly differentiated gastric cancers. The nucleic acid synthesis of proliferatively active tumors could only be partially inhibited by the cytostatica tested (5-fluorouracil, adriamycin). Carcinomas with metabolic possibility for compensation of the active mechanism of the cytostatica were biochemically resistant. Due to the resulting methodical problems and unaccountable patient-dependent causes of resistance, a conclusive statement about cytostatica-sensitive tumors is difficult to make in incorporation studies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528567     DOI: 10.1007/BF00410648

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

1.  Cytokinetic aspects of clinical drug resistance.

Authors:  R A Bender; R L Dedrick
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

2.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

3.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

Review 4.  An overlooked aspect of the mechanism of action of most antineoplastic drugs: the inhibition of macromolecular RNA metabolism.

Authors:  U Torelli
Journal:  Eur J Cancer       Date:  1977-12       Impact factor: 9.162

Review 5.  Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors:  F Valeriote; L van Putten
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

Review 6.  [Antimetabolites].

Authors:  W Wilmanns
Journal:  Internist (Berl)       Date:  1971       Impact factor: 0.743

7.  [Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].

Authors:  M Volm; M Kaufmann; J Mattern; K Wayss
Journal:  Schweiz Med Wochenschr       Date:  1975-01-18

Review 8.  [On the problem of praetherapeutic sensitivity testing of human tumours based on incorporation studies of nucleic acid precursors in vitro (author's transl)].

Authors:  S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1977-12-01

9.  Pretherapeutic cytostatic agent sensitivity testing of breast cancer.

Authors:  P Schlag; G Geier; J Veser; D Breitig; M Betzler; C Herfarth
Journal:  Chir Forum Exp Klin Forsch       Date:  1978

10.  [Studies on the thymidine-triphosphate synthesis in malignant tumors. I. Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis (author's transl)].

Authors:  D Kummer; F Kraml
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-01-21
View more
  2 in total

1.  Effect of fibroblast interferon on colony tumor growth of miscellaneous solid human tumors.

Authors:  P Schlag; J Wolfrum; W Schreml; C Herfarth
Journal:  Klin Wochenschr       Date:  1982-12-01

2.  Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine.

Authors:  B Lehner; P Schlag; W Liebrich; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.